DOI:
10.1055/s-00000009
American Journal of Perinatology
LinksClose Window
References
Kashiwagi T, Okada Y, Nomoto K.
Palivizumab prophylaxis against respiratory syncytial virus infection in children with immunocompromised conditions or down syndrome: a multicenter, post-marketing surveillance in Japan.
Paediatr Drugs 2018;
20 (01) 97-104
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.